TrialInternational journal of clinical oncology2016

Efficacy of aprepitant for the prevention of chemotherapy-induced nausea and vomiting with a moderately emetogenic chemotherapy regimen: a multicenter, placebo-controlled, double-blind, randomized study in patients with gynecologic cancer receiving paclitaxel and carboplatin.

Hideaki Yahata et al.PubMed ↗Publisher ↗

No numbers read from the abstract.